Ticker League

TTM

14.2%

YoY change

+5.70pp

Trough year (2001)

-2.9%

Peak year (2025)

15.3%

FCF Margin history chart for West Pharmaceutical Services (WST) from 1989 to 2025

Latest: 15.3%

FCF Margin change chart for West Pharmaceutical Services (WST) from 1989 to 2025

Latest: +5.70pp

FCF Margin history table for West Pharmaceutical Services (WST) from 1989 to 2025

  • 202515.3%+5.70pp
  • 20249.6%-4.49pp
  • 202314.0%-1.18pp
  • 202215.2%+3.55pp
  • 202111.7%-2.21pp
  • 202013.9%+0.83pp
  • 201913.1%+2.36pp
  • 201810.7%+2.42pp
  • 20178.3%+5.02pp
  • 20163.3%-2.52pp
  • 20155.8%+0.80pp
  • 20145.0%+0.25pp
  • 20134.7%+0.35pp
  • 20124.4%+1.53pp
  • 20112.8%-3.00pp
  • 20105.8%+3.01pp
  • 20092.8%+3.22pp
  • 2008-0.4%-0.37pp
  • 2007-0.0%-5.88pp
  • 20065.9%+1.36pp
  • 20054.5%+2.38pp
  • 20042.1%+0.41pp
  • 20031.7%-2.15pp
  • 20023.9%+6.73pp
  • 2001-2.9%-0.85pp
  • 2000-2.0%-3.30pp
  • 19991.3%+2.55pp
  • 1998-1.3%-8.63pp
  • 19977.4%+0.45pp
  • 19966.9%+3.32pp
  • 19953.6%-2.63pp
  • 19946.2%+4.78pp
  • 19931.4%-2.00pp
  • 19923.4%-2.30pp
  • 19915.7%+4.87pp
  • 19900.9%-1.92pp
  • 19892.8%

FCF Margin values are taken from West Pharmaceutical Services's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About FCF Margin at West Pharmaceutical Services (WST)

According to West Pharmaceutical Services's latest reported financial statements, the company's latest reported free cash flow margin is 14.2%. Free cash flow margin is free cash flow divided by revenue — the share of each sales dollar that converts into cash after capital expenditures. Because free cash flow cannot be inflated by non-cash accounting, FCF margin is a clean read on how efficiently a business turns revenue into deployable cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

West Pharmaceutical Services (WST) most recent annual free cash flow margin stands at 15.26% (2025) – expanded 5.7 percentage points year-over-year.

15.26% stands as the all-time-high annual free cash flow margin, posted in 2025, against a low of -2.87% during 2001.

West Pharmaceutical Services FCF Margin by Year

West Pharmaceutical Services FCF Margin 2025: 15.3%

In 2025, West Pharmaceutical Services reported free cash flow margin of 15.26%, expanded 5.7 percentage points from 2024. This figure represents the highest annual value in the available history.

West Pharmaceutical Services FCF Margin 2024: 9.6%

West Pharmaceutical Services free cash flow margin in 2024 was 9.56%, contracted 4.5 percentage points from 2023.

West Pharmaceutical Services FCF Margin 2023: 14.0%

2023's free cash flow margin for West Pharmaceutical Services came in at 14.05%, contracted 1.2 percentage points from 2022.

West Pharmaceutical Services FCF Margin 2022: 15.2%

West Pharmaceutical Services posted free cash flow margin of 15.23% in 2022, expanded 3.5 percentage points from 2021.

West Pharmaceutical Services FCF Margin 2021: 11.7%

West Pharmaceutical Services free cash flow margin in 2021 was 11.68%.

See more financial history for West Pharmaceutical Services (WST).

Sector peers by FCF Margin

Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest free cash flow margin

Frequently asked questions